TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD

QQQ $ 455.25 $ 5.77 (1.29 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 6.05 (1.12 %)

TLT $ 99.96 $ 0.43 (0.43 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 17.8

Open

$ 18.10

Bid

$ 17.81 x 1,600

Ask

$ 17.82 x 500

Day's Range

$ 17.81 - $ 18.10

52 Week Range

$ 8.06 - $ 19.08

Volume

7,193,544

Average Volume

Market Cap

20.17B

Beta (5Y Monthly)

$ 1.15

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-12-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-02-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	02-10-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	07-27-2022	06-30-2022	10-Q
10	05-03-2022	03-31-2022	10-Q
11	02-09-2022	12-31-2021	10-K
12	10-27-2021	09-30-2021	10-Q
13	07-28-2021	06-30-2021	10-Q
14	04-28-2021	03-31-2021	10-Q
15	02-10-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	02-21-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-02-2019	03-31-2019	10-Q
23	02-19-2019	12-31-2018	10-K
24	11-01-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-03-2018	03-31-2018	10-Q
27	02-12-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Apple Announces New Sleep Apnea Features O...
09/09/2024 17:18:16

jp-morgan-shows-most-interest-in-teva-organon-as-specialty-pharma-sector-exhibits-signs-of-stability

JP Morgan Shows Most Interest In Teva, Org...
09/06/2024 17:46:07

JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva,...

shortage-relief-more-takedas-vyvanse-for-adhd-on-the-way-as-us-ramps-up-production

Shortage Relief: More Takeda's Vyvanse For...
09/06/2024 13:46:26

Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and gl...

Key Takeaways From Teva Pharmaceutical Ind...
09/03/2024 19:01:19

UBS Maintains Buy on Teva Pharmaceutical I...
09/03/2024 14:41:57

UBS analyst Ashwani Verma maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises the price target from $24 to...

novo-nordisks-ozempic-might-be-among-2027-medicare-price-negotiation-targets

Novo Nordisk's Ozempic Might Be Among 2027...
08/23/2024 18:21:18

Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite co...

1000-invested-in-this-stock-5-years-ago-would-be-worth-2400-today

$1000 Invested In This Stock 5 Years Ago W...
08/21/2024 21:30:19

100-invested-in-teva-pharmaceutical-indus-5-years-ago-would-be-worth-this-much-today

$100 Invested In Teva Pharmaceutical Indus...
08/13/2024 21:01:23

Barclays Maintains Overweight on Teva Phar...
08/01/2024 16:50:17

Barclays analyst Balaji Prasad maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target...

tech-stocks-on-track-for-best-session-in-5-months-ahead-of-fed-meeting-small-caps-target-highest-close-since-january-2022-whats-driving-markets-wednesday

Tech Stocks On Track For Best Session In 5...
07/31/2024 17:23:22

Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Commi...

match-group-posts-upbeat-sales-joins-modine-manufacturing-scotts-miracle-gro-nvidia--and-other-big-stocks-moving-higher-on-wednesday

Match Group Posts Upbeat Sales, Joins Modi...
07/31/2024 17:05:44

teva-beats-q2-estimates-raises-annual-outlook-on-strong-generic-austedo-sales

Teva Beats Q2 Estimates, Raises Annual Out...
07/31/2024 14:38:14

Teva Pharmaceutical reported Q2 2024 sales of $4.16 billion, surpassing the $4.06 billion consensus. Revenue rose 7% YoY, drive...

wall-street-remains-on-track-for-amd-led-rebound-ahead-of-fed-decision-meta-earnings-analyst-says-the-bull-tends-to-remain-despite-near-term-volatility

Wall Street Remains On Track For AMD-Led R...
07/31/2024 11:55:46

Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro ...

Teva Pharmaceutical Expects 2024 Adjusted ...
07/31/2024 11:08:02

Teva Pharmaceutical Expects 2024 Revenues ...
07/31/2024 11:06:20

Outlook for 2024 Non-GAAP Results $ billions, except EPS or as noted July 2024 Outlook January 2024 Outlook ...

Teva Pharmaceutical Indus Q2 2024 Adj. EPS...
07/31/2024 11:01:42

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
07/30/2024 17:35:22

apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-rallys-reacceleration-week-ahead-in-earnings

Apple, Amazon, Microsoft, Meta Lead The Ch...
07/29/2024 10:25:11

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...

Teva And Sanofi Fast-Track Anti-TL1A Phase...
07/25/2024 05:47:08

Enrollment acceleration drives earlier-than-anticipated data availability for this potentially best-in-class IBD treatment T...

why-hims--hers-heath-shares-are-surging-today

Why Hims & Hers Heath Shares Are Surging T...
07/22/2024 19:23:33

Hims & Hers Health Inc. (NYSE: HIMS) shares are moving higher on Monday amidst the announcement of Kåre Schultz's appoi...